X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Wockhardt - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs WOCKHARDT LTD. - Comparison Results

WOCKHARDT LTD. 
   Change

Wockhardt is one of the leading domestic pharmaceutical companies with strong presence in the lifestyle segment and a growing focus on biotechnology. While the company made a string of acquisitions in the past namely 'Esparma GmbH' in Germany, 'Pinew... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. WOCKHARDT LTD. FDC LTD./
WOCKHARDT LTD.
 
P/E (TTM) x 22.2 -22.0 - View Chart
P/BV x 5.0 2.2 224.0% View Chart
Dividend Yield % 0.9 0.0 54,759.9%  

Financials

 FDC LTD.   WOCKHARDT LTD.
EQUITY SHARE DATA
    FDC LTD.
Mar-14
WOCKHARDT LTD.
Mar-18
FDC LTD./
WOCKHARDT LTD.
5-Yr Chart
Click to enlarge
High Rs1441,012 14.2%   
Low Rs79532 14.9%   
Sales per share (Unadj.) Rs47.6355.9 13.4%  
Earnings per share (Unadj.) Rs7.6-60.3 -12.6%  
Cash flow per share (Unadj.) Rs9.0-46.8 -19.3%  
Dividends per share (Unadj.) Rs2.250.01 22,500.0%  
Dividend yield (eoy) %2.00 156,084.3%  
Book value per share (Unadj.) Rs47.5257.8 18.4%  
Shares outstanding (eoy) m177.83110.63 160.7%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.32.2 107.8%   
Avg P/E ratio x14.6-12.8 -114.2%  
P/CF ratio (eoy) x12.3-16.5 -74.8%  
Price / Book Value ratio x2.33.0 78.2%  
Dividend payout %29.60 -178,236.6%   
Avg Mkt Cap Rs m19,78485,379 23.2%   
No. of employees `000NA6.3 0.0%   
Total wages/salary Rs m1,2219,371 13.0%   
Avg. sales/employee Rs ThNM6,295.0-  
Avg. wages/employee Rs ThNM1,498.3-  
Avg. net profit/employee Rs ThNM-1,066.3-  
INCOME DATA
Net Sales Rs m8,45939,369 21.5%  
Other income Rs m3941,202 32.7%   
Total revenues Rs m8,85240,571 21.8%   
Gross profit Rs m2,07018 11,312.3%  
Depreciation Rs m2491,495 16.7%   
Interest Rs m312,555 1.2%   
Profit before tax Rs m2,184-2,830 -77.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m0-3,582 0.0%   
Tax Rs m606257 235.6%   
Profit after tax Rs m1,353-6,669 -20.3%  
Gross profit margin %24.50 52,651.9%  
Effective tax rate %27.7-9.1 -305.3%   
Net profit margin %16.0-16.9 -94.4%  
BALANCE SHEET DATA
Current assets Rs m4,35533,796 12.9%   
Current liabilities Rs m1,79226,917 6.7%   
Net working cap to sales %30.317.5 173.4%  
Current ratio x2.41.3 193.6%  
Inventory Days Days4479 56.0%  
Debtors Days Days2589 27.6%  
Net fixed assets Rs m3,02539,664 7.6%   
Share capital Rs m179553 32.3%   
"Free" reserves Rs m8,24327,968 29.5%   
Net worth Rs m8,45328,522 29.6%   
Long term debt Rs m1121,731 0.0%   
Total assets Rs m10,55781,620 12.9%  
Interest coverage x71.4-0.1 -66,421.8%   
Debt to equity ratio x00.8 0.2%  
Sales to assets ratio x0.80.5 166.1%   
Return on assets %13.1-5.0 -260.1%  
Return on equity %16.0-23.4 -68.5%  
Return on capital %23.5-7.7 -306.3%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,1469,807 11.7%   
Fx outflow Rs m3551,789 19.9%   
Net fx Rs m7918,019 9.9%   
CASH FLOW
From Operations Rs m1,485684 217.0%  
From Investments Rs m-6206,302 -9.8%  
From Financial Activity Rs m-753-7,695 9.8%  
Net Cashflow Rs m113-664 -17.0%  

Share Holding

Indian Promoters % 68.9 74.5 92.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 2.3 204.3%  
FIIs % 7.5 7.7 97.4%  
ADR/GDR % 0.0 0.1 -  
Free float % 19.0 15.4 123.4%  
Shareholders   23,730 67,757 35.0%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   ALKEM LABORATORIES  PLETHICO PHARMA  TTK HEALTHCARE  TORRENT PHARMA  FRESENIUS KABI ONCO.  

Compare FDC LTD. With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

WOCKHARDT LTD. Plunges by 6%; BSE HEALTHCARE Index Down 1.5% (Market Updates)

Sep 21, 2018 | Updated on Sep 21, 2018

WOCKHARDT LTD. share price has plunged by 6% and its current market price is Rs 639. The BSE HEALTHCARE is down by 1.5%. The top gainers in the BSE HEALTHCARE Index are BIOCON LTD (up 1.2%) and SANOFI INDIA (up 1.1%). The top losers are WOCKHARDT LTD. (down 6.4%) and SUVEN LIFE (down 5.2%).

WOCKHARDT LTD. Plunges by 6%; BSE HEALTHCARE Index Down 1.5% (Market Updates)

Sep 21, 2018 | Updated on Sep 21, 2018

WOCKHARDT LTD. share price has plunged by 6% and its current market price is Rs 639. The BSE HEALTHCARE is down by 1.5%. The top gainers in the BSE HEALTHCARE Index are BIOCON LTD (up 1.2%) and SYNGENE INTERNATIONAL (up 1.0%). The top losers are WOCKHARDT LTD. (down 6.4%) and SHILPA MEDICARE (down 5.2%).

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. 8-QTR ANALYSIS

COMPARE FDC LTD. WITH

MARKET STATS